In the Journals

Subpectoral biceps tenodesis may produce good outcomes for SLAP tears

A majority of patients with superior labral anterior-posterior tears who underwent subpectoral biceps tenodesis were found to have positive clinical outcomes, according to recently published study findings.

Researchers retrospectively evaluated 28 patients who underwent subpectoral biceps tenodesis for a superior labral anterior-posterior (SLAP) tear and concomitant biceps tendonitis. American Shoulder and Elbow Surgeons (ASES) score, VAS, Simple Shoulder Test (SST), Constant, Single Assessment Numeric Evaluation (SANE) and SF-12 values were recorded. Mean follow-up was 2 years postoperatively.

There were 15, 10, one and two patients who were observed to have intraoperative type I, II, II and IV SLAP tears, respectively. Improvement from preoperative levels was observed at final follow-up in ASES (58 to 89), VAS (1.1 to 3.8), SST (6.3 to 10.6), SANE (54 to 88) and SF-12 component (39 to 50) and overall (35 to 42) values, according to the researchers.

Satisfactory or better outcomes were noted in 80% of patients. – by Christian Ingram

Disclosure: Gupta has no relevant financial disclosures. Please see the full study for a list of all other authors’ relevant financial disclosures.

A majority of patients with superior labral anterior-posterior tears who underwent subpectoral biceps tenodesis were found to have positive clinical outcomes, according to recently published study findings.

Researchers retrospectively evaluated 28 patients who underwent subpectoral biceps tenodesis for a superior labral anterior-posterior (SLAP) tear and concomitant biceps tendonitis. American Shoulder and Elbow Surgeons (ASES) score, VAS, Simple Shoulder Test (SST), Constant, Single Assessment Numeric Evaluation (SANE) and SF-12 values were recorded. Mean follow-up was 2 years postoperatively.

There were 15, 10, one and two patients who were observed to have intraoperative type I, II, II and IV SLAP tears, respectively. Improvement from preoperative levels was observed at final follow-up in ASES (58 to 89), VAS (1.1 to 3.8), SST (6.3 to 10.6), SANE (54 to 88) and SF-12 component (39 to 50) and overall (35 to 42) values, according to the researchers.

Satisfactory or better outcomes were noted in 80% of patients. – by Christian Ingram

Disclosure: Gupta has no relevant financial disclosures. Please see the full study for a list of all other authors’ relevant financial disclosures.